1. 3 Translating endometrial molecular risk stratification to endometrioid ovarian carcinoma: a novel application of precision medicine. (18th September 2019) Authors: Krämer, P; Talhouk, A; Bosse, T; Heitz, F; Singh, N; Kommoss, F; Krämer, B; Hartkopf, A; Brucker, S; McAlpine, J; Koebel, M; Anglesio, M; Kommoss, S Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?. (1st November 2019) Authors: Krämer, P; Talhouk, A; Bosse, T; Heitz, F; Prader, S; Singh, N; Kommoss, F; Krämer, B; Hartkopf, A; Brucker, S; McAlpine, J; Koebel, M; Anglesio, M; Kommoss, S Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP833 The prognostic impact of sphingosine-kinase 1 expression (SphK1) on ovarian cancer. (1st November 2019) Authors: Drosos, Z; Gevensleben, H; Kommoss, S; Karn, T; Holtrich, U; Graeser-Mayer, M; Anglesio, M; El-Balat, A; Rody, A; Hanker, L Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗